Global Cell Free DNA Isolation and Extraction Market - Focus on 25 Country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform - Analysis and Forecast, 2018-2026

  • ID: 4555803
  • Report
  • Region: Global
  • 335 pages
  • BIS Research
1 of 6
Global Cell Free DNA Isolation and Extraction Market to Reach 14,638.3 Thousand units by 2026

FEATURED COMPANIES

  • AccuBioMed
  • BioCAT GmbH
  • GATC Biotech AG.
  • Natera Inc.
  • Omega Bio-tek, Inc
  • QIAGEN
  • MORE

Cell-free DNA are non-encapsulated DNA that enters the bloodstream during apoptosis or necrosis. This cell-free DNA is cleared by macrophages during normal body functioning, but overproduction of cells during cancer produces extra cfDNA in the blood. The CfDNA are found in blood, plasma, serum, or other body fluids and holds clinical significance in diagnosis, monitoring, and detection of various non-invasive diseases. The cfDNA is a screening method for tumors and other fetal DNA studies, they are challenging to extract as they are found in small quantities, and so reliable and consistent methods are required to isolate the less abundant cell-free DNA with higher sensitivity as they have a half-life of about two hours. The global cfDNA extraction and isolation industry is a multi-billion-dollar market which consists of multitudinous companies involved in the development of cfDNA extraction/isolation kits and automated instruments based on various sequencing platforms such as NGS and PCR to bolster the increasing demand for non-invasive screening tests and procedures.

cfDNA extraction and isolation products include extraction/isolation kit, automated instruments, and other consumables to improve the overall non-invasive screening process efficiency. Cell-free DNA testing is a new and efficient technology in which free-flowing DNA fragments from a liquid sample such as saliva, urine, and blood from patients are analyzed to screen a condition or disease. Cell-free DNA testing is essential solutions for the medical diagnostic companies that are facing increasing level of demand for high productivity and cost reduction. The recent advances in Cell-free DNA testing have paved the way for the development of multiple advanced technologies to aid in the battle against cancer and various other diseases including genetic and infectious diseases. The advent of screening procedures such as NIPT and liquid biopsy with improved efficiency of screening results are the most prominent factors facilitating the growth of Cell-free DNA testing in the medical diagnostic industry. Furthermore, these advanced testing procedures have also enabled the companies in the medical diagnostic industry to meet the regulatory compliance as well as manage their profit margins and remain competitive in the market.

The purpose of this study is to gain a holistic view of the Cell-free DNA testing market in terms of various influencing factors, such as recent trends and technological advancements. The scope of this report constitutes an in-depth study of the global Cell-free DNA testing market, including a thorough analysis of the products across different regions. The market has been segmented into ‘product’, ‘platform’, ‘application ‘and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights concerning the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global Cell-free DNA testing market with the help of the key factors driving the market, restraints that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study considers the market share analysis for a comprehensive understanding of the global Cell-free DNA testing market and assesses the factors governing the same. Growth share matrix and detailed pricing analysis have been included in the report. The market by region has been further sub-segmented into various countries, and in each sub-segment, the key market trends, list of the key players, and the recent developments that have taken place have been discussed.

The answers to the following key questions can be derived from this report:

  • What are the major market drivers, challenges and opportunities in the Cell-free DNA testing market?
  • What was the market value of the leading segments and sub-segments of the global Cell-free DNA testing in 2016?
  • How will each segment of the global Cell-free DNA testing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2026?
  • What are the influencing factors that may affect the market share of the key players in Cell-free DNA testing market?
  • How will the Cell-free DNA testing industry evolve during the forecast period 2018- 2026?
  • What are the key developmental strategies that are being implemented by the key players to sustain in this market?
  • What is the market share of each of the companies by NIPT test providers?
  • What is the growth-share matrix of each of the companies by NIPT test providers?
  • Who are the key players in the Cell-free DNA extraction/isolation kits market and what are their contributions?
  • What are the major benefits of the implementation of Cell-free DNA testing in the different field of applications including cancer diagnosis, prenatal testing, and several other chronic diseases?
  • What is the scope of Cell-free DNA testing in the emerging economies of the Asia Pacific and Latin America?
  • What is the scope for expansion by the key players of the Cell-free DNA testing market in the Asia Pacific and Latin America?

The key players who have been contributing significantly to the Cell-free DNA testing market include Agilent Technologies, Inc., Berry Genomics, BGI Diagnostics, BioCAT GmbH, F. Hoffmann-La Roche AG, GATC Biotech AG., Illumina, Inc., Laboratory Corporation of America, LifeCodexx AG, Merck KGaA, Natera Inc., NIPD Genetics, Norgen Biotek Corp., PreAnalytiX GmbH, Premaitha Health Plc, QIAGEN, Quest Diagnostics, SeraCare Life Sciences, Inc., STRATEC Biomedical AG, Thermo Fisher Scientific, AccuBioMed, Aline Biosciences, BioChain, Bioo Scientific Corporation, COVARIS, INC., Epigentek Group Inc., NeoGenStar LLC, Omega Bio-tek, Inc, Promega Corporation, System Biosciences, LLC., and STRECK, INC.,  among others.


Enterprisewide customers will receive an Excel spreadsheet containing data in the report such as tables/market numbers.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • AccuBioMed
  • BioCAT GmbH
  • GATC Biotech AG.
  • Natera Inc.
  • Omega Bio-tek, Inc
  • QIAGEN
  • MORE

Executive Summary

1 Market Overview
1.1 Introduction
1.2 Early Discovery and Applications of cfDNA
1.3 Properties of cfDNA
1.4 Biological Role of cfDNA
1.5 Extraction of Circulating cfDNA
1.6 Application of Circulating cfDNA
1.7 Addressable Market Size and Growth Potential
1.8 Recent Historical Trends 2013-2016 (Parent Market: Genomics)
1.9 Recent Historical Trends 2013-2016 (cfDNA)

2 Market Dynamics
2.1 Promoting and Inhibiting Factors of cfDNA Market Growth
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities

3 Competitive Landscape
3.1 Key Develoments and Stratgies
3.2 Market Share Analysis by Company (2015 and 2016)
3.3 Value Chain Analysis

4 Pricing Analysis
4.1 cfDNA Extraction Kits Pricing Analysis

5 Global Cell Free DNA Extraction and Isolation Market, by Product
5.1 Analysis
5.2 Cell Free DNA Extraction and Isolation Kits
5.3 Cell Free DNA Automated Instruments
5.4 Consumables

6 Global Cell Free DNA Extraction and Isolation Market, by Platform
6.1 Introduction
6.2 Next Generation Sequencing
6.3 Polymerase Chain Reaction (PCR)
6.4 Others

7 Global Cell Free DNA Extraction and Isolation Market, by Applications
7.1 Overview
7.2 Non-Invasive Prenatal Testing (NIPT)
7.3 Oncology
7.4 Transplant Rejection and Other Disease Condition
7.5 Others

8 Global Cell Free DNA Extraction and Isolation Market, by Region
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 U.K.
8.3.4 Italy
8.3.5 Spain
8.3.6 Denmarrk
8.3.7 Others
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Singapore
8.4.4 Japan
8.4.5 Others
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Others
8.6 Rest of the World

9 Company Profiles
9.1 Overview
9.2 Agilent Technologies, Inc.
9.3 AccuBioMed
9.4 Aline Biosciences
9.5 Berry Genomics
9.6 BioChain
9.7 Bioo Scientific Corporation
9.8 BGI Diagnostics
9.9 BioCAT GmbH
9.1 Epigentek Group Inc.
9.11 F. Hoffmann-La Roche AG
9.12 GATC Biotech AG.
9.13 Illumina, Inc.
9.14 Laboratory Corporation of America
9.15 LifeCodexx AG
9.16 Merck KGaA
9.17 Natera Inc.
9.18 NIPD Genetics
9.19 Norgen Biotek Corp
9.2 PreAnalytiX GmbH
9.21 Premaitha Health Plc
9.22 GATC Biotech AG.
9.23 Illumina, Inc.
9.24 Laboratory Corporation of America
9.25 QIAGEN
9.26 Quest Diagnostics
9.27 SeraCare Life Sciences, Inc.
9.28 STRATEC Biomedical AG
9.29 Thermo Fisher Scientific
9.3 NeoGenStar LLC
9.31 Omega Bio-tek, Inc
9.32 Promega Corporation
9.33 System Biosciences, LLC.
9.34 STRECK, INC.

10 Report Scope & Methodology
10.1 Scope of the Report
10.2 Global Cell Free DNA Extraction and Isolation Market Segmentation
10.3 Research Methodology
10.3.1 Primary Research
10.3.2 Secondary Research
10.3.3 Key Data Points from Primary Sources
10.3.4 Key Data Points from Secondary Sources
10.3.5 Data Triangulation
10.3.6 Top-Down Approach (Segment wise Analysis)
10.3.7 Bottom-Up Approach (Segmental Analysis)
10.4 Assumptions and Limitations
10.5  Data and Prediction Modelling

List of Tables
1 Global cfDNA Extraction/Isolation Market
2 Advanced Technologies Employed for Circulating cell-free DNA
3 Market Share Analysis
4 cfDNA Extraction Kits Pricing Analysis
5 Global cfDNA Extraction/Isolation Market by Product ($Million)
6 By Product : Extraction/Isolation Kits: Key Players
7 List of Some Commercially Available Isolation Kits
8 Sales of Key Isolation Kits ($Million)
9 cfDNA Extraction/Isolation Kits Market by Method ($Million)
10 cfDNA Extraction/Isolation Kits Market by Method (Sample Processed, In Thousand Units)
11 By Product : Automated Instruments: Key Players
12 By Product : Consumables: Key Players
13 Product Analysis
14 Global cfDNA Extraction/Isolation Market by Platform ($Million)
15 Global cfDNA Extraction/Isolation Market by Platform (Sample Volume in Thousand)
16 Comparison between Next Generation Sequencing (NGS) and Polymerase Chain Reaction (dPCR)
17 Global cfDNA Extraction/Isolation Market by Application ($Million)
18 Global cfDNA Extraction/Isolation Market by Application (Sample Volume in Thousand)
19 Growth Share Matrix by cfDNA NIPT Test Providers
20 Global cfDNA Extraction/Isolation Market by Region ($Million)
21 Global cfDNA Extraction/Isolation Market by Region (Sample Volume in Thousand)
22 Key Players of North America
23 Key Players of Europe
24 Key Players of Asia Pacific
25 Key Players of Latin America and RoW
26 Latin America and RoW Market
27 List of Qiagen products for cfDNA
28 Thermo Fisher Scientific: Product Portfolio

List of Figures
1 Global cfDNA Extraction and Isolation Market, 2016 and 2026
2 Global cfDNA Extraction and Isolation Market Value & Forecast, 2016–2026 (US$ Million)
3 Global cfDNA Extraction/Isolation Market  Segmentation (Value)
4 Global cfDNA Extraction/Isolation Volume by Extraction Technology
5 Global cfDNA Extraction/Isolation Share by Extraction Technology, 2016
6 Global cfDNA Extraction/Isolation Share by Extraction Technology, 2026
7 Market Penetration of Automation Systems (Area Represent the Penetration Share), 2016
8 Global cfDNA Extraction/Isolation Market by Application (US$ Mn), 2016-2026
9 Global cfDNA Extraction/Isolation Market by Application, 2016
10 Global cfDNA Extraction/Isolation Market by Application, 2026
11 Global cfDNA Extraction/Isolation Market by Application (US$ Mn)
12 Global cfDNA Extraction/Isolation Market by End-User, 2016
13 Global cfDNA Extraction/Isolation Market by End-User, 2026
14 Global cfDNA Extraction/Isolation Market by Platform/technique (US$ Mn)
15 Global cfDNA Extraction/Isolation Market by Platform/technique, 2016
16 Global cfDNA Extraction/Isolation Market by Platform/technique (US$ Mn), 2026
17 Global cfDNA Extraction/Isolation Market by region, 2016
18 Global cfDNA Extraction/Isolation Market, by Region 2023
19 Global cfDNA Extraction/Isolation Market Growth Rate by Region
20 Global cfDNA Extraction/Isolation Market, 2016-2026 (US$ Mn)
21 Global cfDNA Extraction/Isolation Market, 2016-2026 (Sample processed Volume)
22 Global cfDNA Extraction/Isolation Market by Application ($Million)
23 Global cfDNA Extraction/Isolation Market by Application (Test Volume, Units)
24 Global cfDNA Extraction/Isolation Market ($Million)
25 Total cfDNA Isolation Volume by Major Countries ($Million), 2016 & 2026
26 Global cfDNA Extraction/Isolation Market by Region 2016
27 Global cfDNA Extraction/Isolation Market by Region 2023
28 North America cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
29 Europe cfDNA Extraction/Isolation Market Growth Pattern, 2016-2027
30 Asia Pacific cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
31 Latin America cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
32 Global Research Genomics Market, 2016 (US$ Bn)
33 Global Clinical Genomics Market, 2016 (US$ Bn)
34 Recent Historical Trends 2013-2016 (cfDNA): Prenatal Testing
35 Company/Laboratory Offering cfDNA Test (NIPT and Cancer) 
36 cfDNA Based Test Volume, 2011-2026
37 Market Share Analysis, 2015
38 Market Share Analysis, 2016
39 Value Chain
40 Global cfDNA extraction/isolation market: By Product
41 Global cfDNA extraction/Isolation Market by Products ($Million)
42 Global cfDNA Extraction/Isolation Market Share by Product 2016
43 Global cfDNA Extraction/Isolation Market Share by Product 2026
44 Global cfDNA Extraction/Isolation Kits Market ($Million)
45 Global cfDNA Automated Extraction System Market ($Million)
46 Global cfDNA Other Consumables Market ($Million)
47 Global Magnetic bead-based cfDNA Extraction Kits Market ($Million)
48 Global Magnetic bead-based cfDNA Extraction Kits Market (In Thousand Units)
49 Global Column based cfDNA Extraction Kits Market (US$ Mn)
50 Global Column based cfDNA Extraction Kits Market (In Thousand Units)
51 Global Other cfDNA Extraction Kits Market (US$ Mn)
52 Global Other cfDNA Extraction Kits Market (In Thousand Units)
53 Global Automated Instruments cfDNA Extraction System Market ($Million)
54 Global Consumables cfDNA Extraction Market ($Million)
55 Global cfDNA Extraction/Isolation Market ($Million)
56 Global cfDNA Extraction/Isolation Market (Sample Volume, Thousand Units)
57 Global cfDNA Extraction Isolation Market Growth Rate by Revenue
58 Global cfDNA Extraction Isolation Market Growth Rate by Volume
59 Growth Share Matrix by Platform, 2016
60 cfDNA NGS Market, 2016-2026 ($Million)
61 cfDNA NGS Market, 2016-2026 (Test Volume, in Thousand Units)
62 rPCR and Multiplexed PCR Based cfDNA Processing Volume (Thousand Units)
63 rPCR and Multiplexed PCR Based cfDNA Processing Revenue
64 qPCR Based cfDNA Processing Revenue
65 qPCR Based cfDNA Processing Volume (Thousand Units)
66 dPCR Based cfDNA Processing Volume (Thousand Units)
67 dPCR Based cfDNA Processing Revenue
68 cfDNA Quantification Breakdown by Type of PCR, 2016
69 cfDNA Quantification Breakdown by Type of PCR, 2026
70 Global cfDNA Extraction/Isolation Market by Application ($Million)
71 Global cfDNA Extraction/Isolation Market by Application, 2016
72 Global cfDNA Extraction/Isolation Market by Application, 2026
73 Global Oncology cfDNA Extraction/Isolation Market ($Million)
74 Global Oncology cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
75 Cobas EGFR Mutation Test v2 Volume Growth Projection
76 Global NIPT cfDNA Extraction/Isolation Market ($Million)
77 Global NIPT cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
78 Global NIPT cfDNA Market Share Analysis (by Test Volume), 2016
79 Global NIPT cfDNA Market Share Analysis (by Test Volume), 2026
80 Growth Share Matrix by cfDNA NIPT Test Providers
81 Global NIPT Market Revenue by Region ($Million)
82 Global NIPT Test Volume by Region (Units)
83 Global Other cfDNA Extraction/Isolation Market ($Million)
84 Global Other cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
85 Global cfDNA Extraction/Isolation Market by Region, 2016
86 Global cfDNA Extraction/Isolation Market by Region, 2026
87 North America cfDNA Extraction/Isolation Market ($Million)
88 North America cfDNA Extraction/Isolation Market
89 U.S. cfDNA Extraction Kits Market (US$ Mn)
90 U.S. cfDNA Extraction Kits Market (In Thousand Units)
91 Canada cfDNA Extraction Kits Market (US$ Mn)
92 Canada cfDNA Extraction Kits Market (In Thousand Units)
93 U.K. cfDNA Extraction Kits Market ($Million)
94 U.K. cfDNA Extraction Kits Market (In Thousand Units)
95 Germany cfDNA Extraction Kits Market ($Million)
96 Germany cfDNA Extraction Kits Market (In Thousand Units)
97 France cfDNA Extraction Kits Market ($Million)
98 France cfDNA Extraction Kits Market (In Thousand Units)
99 Rest of Europe cfDNA Extraction Kits Market ($Million)
100 Rest of Europe cfDNA Extraction Kits Market (In Thousand Units)
101 Asia Pacific cfDNA Extraction/Isolation Market ($Million)
102 China cfDNA Extraction Kits Market ($Million)
103 China cfDNA Extraction Kits Market (In Thousand Units)
104 Japan cfDNA Extraction Kits Market ($Million)
105 Japan cfDNA Extraction Kits Market (In Thousand Units)
106 India cfDNA Extraction Kits Market ($Million)
107 India cfDNA Extraction Kits Market (In Thousand Units)
108 Agilent Technologies, Inc.: Product Portfolio
109 Agilent Technologies, Inc.: Overall Financials (2014-2016)
110 Agilent Technologies, Inc.: Revenue by Business Segment (2014-2016)
111 Agilent Technologies, Inc.: Revenue by Region (2014-2016)
112 Agilent Technologies, Inc.: SWOT Analysis
113 Berry Genomics: Product Portfolio
114 Berry Genomics: SWOT Analysis
115 BGI Diagnostics: Product Portfolio
116 BGI Diagnostics: SWOT Analysis
117 BioCAT GmbH: Product Portfolio
118 BioCat GmbH: SWOT Analysis
119 F. Hoffmann-La Roche AG: Product/Service Mapping
120 F. Hoffmann-La Roche AG: Net Revenue (2014-2016)
121 F. Hoffmann-La Roche AG: Revenue by Region (2014-2016)
122 F. Hoffmann-La Roche AG: Revenue by Divisions (2014-2016)
123 F. Hoffmann-La Roche AG: : Revenue By Diagnostics Sub-division (2014-2016)
124 F. Hoffmann-La Roche AG: SWOT Analysis
125 GATC Biotech AG: Product Portfolio
126 GATC Biotech AG: SWOT Analysis
127 Illumina, Inc.: Product Portfolio
128 Illumina, Inc.: Overall Financials (2014-2016)
129 Illumina, Inc.: Net revenue, Product revenue and Service revenue (2014-2016)
130 Illumina, Inc.: Revenue by Region, (2014-2016)
131 Illumina, Inc.: SWOT Analysis
132 Laboratory Corporation of America: Product/Service Portfolio
133 Laboratory Corporation of America: Overall Financials (2014-2016)
134 Laboratory Corporation of America: Revenue by Business Segment (2014-2016)
135 Laboratory Corporation of America: Geographic Distribution of Net Revenues (2016)
136 Laboratory Corporation of America: SWOT Analysis
137 LifeCodexx AG: Product Portfolio
138 LifeCodexx AG: SWOT Analysis
139 Merck KGaA: Product/Service Portfolio (Sigma-Aldrich, a Subsidiary of Merck)
140 Merck KGaA: Overall Financials (2014-2016)
141 Merck KGaA: Net Revenue by Business Segments, (2014-2016)
142 Merck KGaA: Revenue by Region (2014-2016)
143 Merck KGaA: SWOT Analysis
144 Natera Inc.: Product/Service Portfolio
145 Natera Inc.: Overall Financials (2014-2016)
146 Natera Inc.: Revenue by Region (2014-2016)
147 Natera Inc.: SWOT Analysis
148 NIPD Genetics: Product Portfolio
149 NIPD Genetics: SWOT Analysis
150 Norgen Biotek Corp.: Product Portfolio
151 Norgen Biotek Corp.: SWOT Analysis
152 PreAnalytiX GmbH: Product Portfolio
153 PreAnalytiX GmbH: SWOT Analysis
154 Premaitha Health Plc: Product Portfolio
155 Premaitha Health Plc: Overall Financials (2014-2016)
156 Premaitha Health Plc: Revenue by Region (2014-2016)
157 Premaitha Health Plc: SWOT Analysis
158 QIAGEN: Product and Service Portfolio
159 QIAGEN: Overall Financials (2014-2016)
160 QIAGEN: Net Revenue by Business Segment (2014-2016)
161 QIAGEN: Net Revenue by Region (2014-2016)
162 QIAGEN: SWOT Analysis
163 Quest Diagnostics: Product Portfolio
164 Quest Diagnostics: Overall Financials (2014-2016)
165 Quest Diagnostics: Revenue by Business Segment (2014-2016)
166 Quest Diagnostics: Revenue by DIS segment (2014-2016)
167 Quest Diagnostics: SWOT Analysis
168 SeraCare Life Sciences, Inc.: Product Portfolio
169 SeraCare Life Sciences, Inc.: SWOT Analysis
170 STRATEC Biomedical AG: Product Portfolio (Stratec Molecular GmbH, a subsidiary of Stratec Biomedical AG)
171 Stratec Biomedical AG: Overall Financials (2014-2016)
172 Stratec Biomedical AG: Revenue by Region (2014-2016)
173 Stratec Biomedical AG: Revenue by Business Segment (2014-2016)
174 Stratec Biomedical AG: Revenue by Business Segment 2014
175 STRATEC Biomedical AG: SWOT Analysis
176 Thermo Fisher Scientific: Overall Financials (2014-2016)
177 Thermo Fisher Scientific: Net Revenue by Business Segment (2014-2016)
178 Thermo Fisher Scientific: Net Revenue by Region (2014-2016)
179 Thermo Fisher Scientific: SWOT Analysis
180 AccuBioMed: Product Portfolio
181 Aline Biosciences: Product Portfolio
182 BioChain: Product Portfolio
183 Bioo Scientific Corporation: Product Portfolio
184 Covaris, Inc.: Product Portfolio
185 Epigentek Group Inc.: Product Portfolio
186 NeoGenStar LLC: Product Portfolio
187 Omega Bio-tek, Inc.: Product Portfolio
188 Promega Corporation: Product Portfolio
189 System Biosciences, LLC: Product Portfolio

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • AccuBioMed
  • BioCAT GmbH
  • GATC Biotech AG.
  • Natera Inc.
  • Omega Bio-tek, Inc
  • QIAGEN
  • MORE

Biomarker play an important role in development of translational medicine, which facilitates translation of basic research into medical advances. In line with this, most pharmaceutical and biotechnology companies are committing to associate their therapeutic drugs with diagnostic assays to monitor the drug response as number of biomarkers are directly associated with drugs. For instance, Thermo Fisher Scientific in collaboration with Novartis AG, Pfizer Inc. and GlaxoSmithKline Plc. is developing multi-market universal next-generation sequencing for multiple companion diagnostic programs, which will help pharma companies to match cancer patients with specific drug candidate

Early detection of cancer requires suitable diagnostic procedures to screen asymptomatic population which is on average risk of cancer, particularly for breast cancer, cervical cancers, colon cancers and melanoma. Increasing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among general population. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective diagnostic tests for cancer. The cell-free DNA isolation and extraction market drivers includes inclusion of cancer screening tests in national cancer screening programs, increasing discretionary funding for cancer research, associating drugs with diagnostic assays, constantly growing list of cancer biomarkers, exploring next-generation sequencing techniques for cancer diagnostics and others. Market restrains includes lack of standardization and appropriate controls of cell free DNA kits, insurance coverage and reimbursement issues and enormous R&D investment with no therapeutic result.

The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy. North America is the leading contributor to the global cell free DNA isolation and extraction market, in terms of both, volume and revenue. The contribution of North America to the global cell free DNA isolation and extraction market was volume and valued to be approximately 59% and 61% in 2016, respectively. However, Asia Pacific is expected to grow, by volume, at an impressive 21.15% CAGR during the forecast period. The extraction kits hold the largest share of the total cfDNA extraction/isolation market and growing at a double digit CAGR. Furthermore, with magnetic bead-based kits, proteinase and heat treatment are unnecessary, enabling all the processes to be conducted at room temperature. As compared to traditional cfDNA extraction methods, there is also a significant reduction in processing and hands-on time.

Among the applications, non-invasive prenatal testing (NIPT) leads the cfDNA extraction/isolation market share. In 2016, the NIPT segment accounted for 72% of the total market. However, the market share of NIPT segment is expected to decrease substantially during the forecast period owing high market penetration rate of cfDNA technology in the cancer diagnostic and screening application. In 2016, next generation sequencing was the most used downstream quantification technique for cfDNA and accounted for 71% of the total sample processing share and is expected to remain the leading quantification technique in 2026.

This market intelligence report provides a multidimensional view of the global cell free DNA isolation and extraction market in terms of market size and growth potential. This research report aims at answering various aspects of the global cell free DNA isolation and extraction market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales, and manufacturers, and trend analysis by segments and demand analysis by geographical regions.

The report also profiles  companies including several key players, such as Agilent Technologies, Inc., Berry Genomics, BGI Diagnostics, BioCAT GmbH, F. Hoffmann-La Roche AG, GATC Biotech AG., Illumina, Inc., Laboratory Corporation of America, LifeCodexx AG, Merck KGaA, Natera Inc., NIPD Genetics, Norgen Biotek Corp., PreAnalytiX GmbH, Premaitha Health Plc, QIAGEN, Quest Diagnostics, SeraCare Life Sciences, Inc., STRATEC Biomedical AG, Thermo Fisher Scientific, AccuBioMed, Aline Biosciences, BioChain, Bioo Scientific Corporation, COVARIS, INC., Epigentek Group Inc., NeoGenStar LLC, Omega Bio-tek, Inc, Promega Corporation, System Biosciences, LLC., and STRECK, INC.,  among others.

Note: Product cover images may vary from those shown
5 of 6
  • AccuBioMed
  • Agilent Technologies, Inc.
  • Aline Biosciences
  • BGI Diagnostics
  • Berry Genomics
  • BioCAT GmbH
  • BioChain
  • Bioo Scientific Corporation
  • Epigentek Group Inc.
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG.
  • Illumina, Inc.
  • Laboratory Corporation of America
  • LifeCodexx AG
  • Merck KGaA
  • NIPD Genetics
  • Natera Inc.
  • NeoGenStar LLC
  • Norgen Biotek Corp
  • Omega Bio-tek, Inc
  • PreAnalytiX GmbH
  • Premaitha Health Plc
  • Promega Corporation
  • QIAGEN
  • Quest Diagnostics
  • STRATEC Biomedical AG
  • STRECK, INC.
  • SeraCare Life Sciences, Inc.
  • System Biosciences, LLC.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll